tiprankstipranks
Advertisement
Advertisement

UTHR Stock Latest News

United Therapeutics price target raised to $486 from $466 at Wells Fargo
The FlyUnited Therapeutics price target raised to $486 from $466 at Wells Fargo
2d ago
INSM
LQDA
United Therapeutics price target raised to $625 from $525 at Cantor Fitzgerald
PremiumThe Fly
United Therapeutics price target raised to $625 from $525 at Cantor Fitzgerald
13d ago
UTHR
United Therapeutics Launches Major Accelerated Share Repurchase Program
PremiumCompany Announcements
United Therapeutics Launches Major Accelerated Share Repurchase Program
16d ago
8K
UTHR
United Therapeutics announces $2B share repurchase program, $1.5B ASR
PremiumThe Fly
United Therapeutics announces $2B share repurchase program, $1.5B ASR
16d ago
UTHR
MannKind price target lowered to $8 from $10 at Wedbush
PremiumThe Fly
MannKind price target lowered to $8 from $10 at Wedbush
20d ago
MNKD
UTHR
United Therapeutics price target raised to $705 from $655 at UBS
PremiumThe FlyUnited Therapeutics price target raised to $705 from $655 at UBS
20d ago
UTHR
United Therapeutics price target raised to $560 from $500 at Argus
Premium
The Fly
United Therapeutics price target raised to $560 from $500 at Argus
21d ago
UTHR
United Therapeutics price target raised to $668 from $640 at Jefferies
Premium
The Fly
United Therapeutics price target raised to $668 from $640 at Jefferies
23d ago
UTHR
United Therapeutics price target raised to $615 from $600 at Leerink
PremiumThe Fly
United Therapeutics price target raised to $615 from $600 at Leerink
23d ago
UTHR
United Therapeutics’ Ralinepag Trial Success Boosts PAH Outlook
PremiumCompany Announcements
United Therapeutics’ Ralinepag Trial Success Boosts PAH Outlook
23d ago
8K
UTHR
United Therapeutics says phase 3 ADVANCE OUTCOMES study met its primary endpoint
PremiumThe Fly
United Therapeutics says phase 3 ADVANCE OUTCOMES study met its primary endpoint
23d ago
UTHR
United Therapeutics Earnings Call Signals Growth Ahead
PremiumCompany Announcements
United Therapeutics Earnings Call Signals Growth Ahead
25d ago
UTHR
MannKind downgraded to Sector Perform from Outperform at RBC Capital
PremiumThe FlyMannKind downgraded to Sector Perform from Outperform at RBC Capital
26d ago
MNKD
UTHR
United Therapeutics price target raised to $600 from $525 at H.C. Wainwright
Premium
The Fly
United Therapeutics price target raised to $600 from $525 at H.C. Wainwright
27d ago
UTHR
United Therapeutics price target raised to $643 from $587 at RBC Capital
Premium
The Fly
United Therapeutics price target raised to $643 from $587 at RBC Capital
27d ago
UTHR
United Therapeutics price target raised to $600 from $575 at Oppenheimer
PremiumThe Fly
United Therapeutics price target raised to $600 from $575 at Oppenheimer
27d ago
UTHR
United Therapeutics price target raised to $471 from $447 at Morgan Stanley
PremiumThe Fly
United Therapeutics price target raised to $471 from $447 at Morgan Stanley
27d ago
UTHR
United Therapeutics price target raised to $466 from $423 at Wells Fargo
PremiumThe Fly
United Therapeutics price target raised to $466 from $423 at Wells Fargo
28d ago
UTHR
Balancing Franchise Headwinds and Pipeline Upside: Rationale Behind a Hold on United Therapeutics
PremiumRatings
Balancing Franchise Headwinds and Pipeline Upside: Rationale Behind a Hold on United Therapeutics
28d ago
UTHR
United Therapeutics price target raised to $569 from $546 at BofA
PremiumThe FlyUnited Therapeutics price target raised to $569 from $546 at BofA
28d ago
UTHR
RBC says United Therapeutics TreSMI presents ‘material risk’ to MannKind
Premium
The Fly
RBC says United Therapeutics TreSMI presents ‘material risk’ to MannKind
28d ago
MNKD
UTHR
Leerink sees MannKind selloff as ‘overreaction’ to headline news
Premium
The Fly
Leerink sees MannKind selloff as ‘overreaction’ to headline news
28d ago
MNKD
UTHR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >